Among 40 non-Hodgkin lymphoma (NHL) of Waldeyer's ring patients, the percentage of the patients at stage I / II was 80%; low to low-intermediate International prognosis index (IPI) accounted for 92.5%; the most common pathologic subtype was B cell NHL (92%), which was mostly treated by RCHOP chemotherapy, and the rest was T cell NHL treated by CHOP chemotherapy.